{"pmid":32478398,"title":"Successful smallpox eradication: what can we learn to control COVID-19?","text":["Successful smallpox eradication: what can we learn to control COVID-19?","J Travel Med","Heymann, D L","Wilder-Smith, Annelies","32478398"],"journal":"J Travel Med","authors":["Heymann, D L","Wilder-Smith, Annelies"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32478398","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1093/jtm/taaa090","keywords":["act accelerator","dr tedros","sars-cov-2","who","global coordination","pandemic","public health emergency of international concern","solidarity"],"topics":["Prevention"],"weight":1,"_version_":1668532089503350784,"score":9.490897,"similar":[{"pmid":32399903,"title":"[The \"Historic Study\" SOLIDARITY-Research's Answer to the Sars-CoV-2 Pandemic].","text":["[The \"Historic Study\" SOLIDARITY-Research's Answer to the Sars-CoV-2 Pandemic].","This paper is part of Forum COVID-19: Perspectives in the Humanities and Social Sciences. The novel coronavirus (Sars-CoV-2) poses a huge challenge to the world community. Knowledge about the virus and its properties is limited, but there is a great need to base political and medical decisions on scientific knowledge. This situation is leading to a dynamization of research. A prominent example of such a development is SOLIDARITY. The epistemological dimensions of this trial, which is coordinated by the WHO, and the resulting ethical implications are discussed in this article.","NTM","Gadebusch Bondio, Mariacarla","Marloth, Maria","32399903"],"abstract":["This paper is part of Forum COVID-19: Perspectives in the Humanities and Social Sciences. The novel coronavirus (Sars-CoV-2) poses a huge challenge to the world community. Knowledge about the virus and its properties is limited, but there is a great need to base political and medical decisions on scientific knowledge. This situation is leading to a dynamization of research. A prominent example of such a development is SOLIDARITY. The epistemological dimensions of this trial, which is coordinated by the WHO, and the resulting ethical implications are discussed in this article."],"journal":"NTM","authors":["Gadebusch Bondio, Mariacarla","Marloth, Maria"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32399903","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s00048-020-00257-5","keywords":["covid-19","evidence-based medicine","research ethics","solidarity","who"],"weight":0,"_version_":1666865855086985218,"score":111.179436},{"pmid":32446538,"title":"Ongoing Challenges Faced in the Global Control of COVID-19 Pandemic.","text":["Ongoing Challenges Faced in the Global Control of COVID-19 Pandemic.","The recent pandemic caused by SARS-CoV-2 has now spread worldwide and caused more than 51,000 deaths, by April 2nd 2020. As predicted, there are several obstacles for medical and governmental authorities to efficiently manage this respiratory illness. In spite of appropriated supplies, most hospitals are suffering from a scarcity of free beds, protective masks, sanitizing liquids and even ECMO machines for patients with severe cases. Defeating this pandemic is impossible without united and coordinated international attempts shaped by all countries of the world. We believe that an international scaled-determination is required to diminish the complex impacts of pandemic. The most important priorities are supposed to be i) The development of potential vaccine candidates to provide protection and interrupt the transmission of SARS-CoV-2, ii) To ensure enough supplies for hospitals and their homogeneous distribution among the countries with the worst number of severe cases, iii) There is a need for more studies to identify potential treatments that are effective for the control of this viral infection and iv) It is imperative to provide easy access to diagnostic kits for all countries affected by this pandemic. In the light of these suggestions, it would be recommendable to at least temporarily abandon the political checkouts in both national and international levels; therefore, all partners will be potentially able to efficiently enforce their strategies for the elimination of this unique threat to the human populations.","Arch Med Res","Perez Perez, Guillermo I","Talebi Bezmin Abadi, Amin","32446538"],"abstract":["The recent pandemic caused by SARS-CoV-2 has now spread worldwide and caused more than 51,000 deaths, by April 2nd 2020. As predicted, there are several obstacles for medical and governmental authorities to efficiently manage this respiratory illness. In spite of appropriated supplies, most hospitals are suffering from a scarcity of free beds, protective masks, sanitizing liquids and even ECMO machines for patients with severe cases. Defeating this pandemic is impossible without united and coordinated international attempts shaped by all countries of the world. We believe that an international scaled-determination is required to diminish the complex impacts of pandemic. The most important priorities are supposed to be i) The development of potential vaccine candidates to provide protection and interrupt the transmission of SARS-CoV-2, ii) To ensure enough supplies for hospitals and their homogeneous distribution among the countries with the worst number of severe cases, iii) There is a need for more studies to identify potential treatments that are effective for the control of this viral infection and iv) It is imperative to provide easy access to diagnostic kits for all countries affected by this pandemic. In the light of these suggestions, it would be recommendable to at least temporarily abandon the political checkouts in both national and international levels; therefore, all partners will be potentially able to efficiently enforce their strategies for the elimination of this unique threat to the human populations."],"journal":"Arch Med Res","authors":["Perez Perez, Guillermo I","Talebi Bezmin Abadi, Amin"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32446538","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.arcmed.2020.04.016","keywords":["covid-19","challenge","pandemic","sars-cov-2","who","wuhan"],"topics":["Prevention"],"weight":1,"_version_":1667698385900011521,"score":73.82478},{"pmid":32419024,"title":"Epidemic curve and reproduction number of COVID-19 in Iran.","text":["Epidemic curve and reproduction number of COVID-19 in Iran.","COVID-19 was first reported in Iran on 19 February, 2020. We estimated the initial basic reproduction number to be 4.86. With increasingly stringent public health measures, the effective reproduction number declined to below 1 after 2 months.","J Travel Med","Sahafizadeh, Ebrahim","Sartoli, Samaneh","32419024"],"abstract":["COVID-19 was first reported in Iran on 19 February, 2020. We estimated the initial basic reproduction number to be 4.86. With increasingly stringent public health measures, the effective reproduction number declined to below 1 after 2 months."],"journal":"J Travel Med","authors":["Sahafizadeh, Ebrahim","Sartoli, Samaneh"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32419024","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1093/jtm/taaa077","keywords":["sars-cov-2","isolation","mitigation","nonpharmaceutical interventions","pandemic","public health emergency of international concern","quarantine"],"locations":["Iran","Iran"],"countries":["Iran, Islamic Republic of"],"countries_codes":["IRN|Iran, Islamic Republic of"],"topics":["Prevention","Epidemic Forecasting"],"weight":1,"_version_":1667254896768843776,"score":61.25744},{"pmid":32328954,"title":"Clinical Pathway for Early Diagnosis of COVID-19: Updates from Experience to Evidence-Based Practice.","text":["Clinical Pathway for Early Diagnosis of COVID-19: Updates from Experience to Evidence-Based Practice.","The COVID-19 pandemic is a significant global event in the history of infectious diseases. The SARS-CoV-2 appears to have originated from bats but is now easily transmissible among humans, primarily through droplet or direct contact. Clinical features of COVID-19 include high fever, cough, and fatigue which may progress to ARDS. Respiratory failure can occur rapidly after this. The primary laboratory findings include lymphopenia and eosinopenia. Elevated D-dimer, procalcitonin, and CRP levels may correlate with disease severity. Imaging findings include ground-glass opacities and patchy consolidation on CT scan. Mortality is higher in patients with hypertension, cardiac disease, diabetes mellitus, cancer, and COPD. Elderly patients are more susceptible to severe disease and death, while children seem to have lower rates of infection and lower mortality. Diagnostic criteria and the identification of persons under investigation have evolved as more data has emerged. However, the approach to diagnosis is still very variable from region to region, country to country, and even among different hospitals in the same city. The importance of a clinical pathway to implement the most effective and relevant diagnostic strategy is of critical importance to establish the control of this virus that is responsible for more and more deaths each day.","Clin Rev Allergy Immunol","Xu, Guogang","Yang, Yongshi","Du, Yingzhen","Peng, Fujun","Hu, Peng","Wang, Runsheng","Yin, Ming","Li, Tianzhi","Tu, Lei","Sun, Jinlyu","Jiang, Taijiao","Chang, Christopher","32328954"],"abstract":["The COVID-19 pandemic is a significant global event in the history of infectious diseases. The SARS-CoV-2 appears to have originated from bats but is now easily transmissible among humans, primarily through droplet or direct contact. Clinical features of COVID-19 include high fever, cough, and fatigue which may progress to ARDS. Respiratory failure can occur rapidly after this. The primary laboratory findings include lymphopenia and eosinopenia. Elevated D-dimer, procalcitonin, and CRP levels may correlate with disease severity. Imaging findings include ground-glass opacities and patchy consolidation on CT scan. Mortality is higher in patients with hypertension, cardiac disease, diabetes mellitus, cancer, and COPD. Elderly patients are more susceptible to severe disease and death, while children seem to have lower rates of infection and lower mortality. Diagnostic criteria and the identification of persons under investigation have evolved as more data has emerged. However, the approach to diagnosis is still very variable from region to region, country to country, and even among different hospitals in the same city. The importance of a clinical pathway to implement the most effective and relevant diagnostic strategy is of critical importance to establish the control of this virus that is responsible for more and more deaths each day."],"journal":"Clin Rev Allergy Immunol","authors":["Xu, Guogang","Yang, Yongshi","Du, Yingzhen","Peng, Fujun","Hu, Peng","Wang, Runsheng","Yin, Ming","Li, Tianzhi","Tu, Lei","Sun, Jinlyu","Jiang, Taijiao","Chang, Christopher"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32328954","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1007/s12016-020-08792-8","keywords":["acute respiratory distress syndrome","cdc","covid-19","clinical pathway","coronavirus","infection","outbreak","pandemic","pneumonia","quarantine","sars-cov-2","transmission","virus","who"],"locations":["lymphopenia","eosinopenia"],"topics":["Diagnosis"],"weight":1,"_version_":1666138494676762624,"score":59.67459},{"pmid":32229157,"title":"Practical Strategies Against the Novel Coronavirus and COVID-19-the Imminent Global Threat.","text":["Practical Strategies Against the Novel Coronavirus and COVID-19-the Imminent Global Threat.","The last month of 2019 harbingered the emergence of a viral outbreak that is now a major public threat globally. COVID-19 was first diagnosed and confirmed in a couple of cases with unknown pneumonia; the patients lived in, or travelled to, Wuhan, the capital of China's Hubei province. People now face a complex challenge that deserves urgent intervention by all involved in medical healthcare globally. Conventional antiviral therapies or vaccines are the most referred means of tackling the virus, but we think establishing these ideal management strategies is presently far-fetched. In-house isolation or quarantine of suspected cases to keep hospital admissions manageable and prevent in-hospital spread of the virus, and promoting general awareness about transmission routes are the practical strategies used to tackle the spread of COVID-19. Cases with weakened or compromised immune systems-for example, elderly individuals, young children, and those with pre-existing conditions such as diabetes, cancer, hypertension, and chronic respiratory diseases-are particularly more susceptible to COVID-19. Hopefully, cumulative data using whole-genome sequencing of the SARS-CoV-2 genome in parallel with mathematical modeling will help the molecular biologists to understand unknown features of the pathogenesis and epidemiology of COVID-19.","Arch Med Res","Rahimi, Farid","Talebi Bezmin Abadi, Amin","32229157"],"abstract":["The last month of 2019 harbingered the emergence of a viral outbreak that is now a major public threat globally. COVID-19 was first diagnosed and confirmed in a couple of cases with unknown pneumonia; the patients lived in, or travelled to, Wuhan, the capital of China's Hubei province. People now face a complex challenge that deserves urgent intervention by all involved in medical healthcare globally. Conventional antiviral therapies or vaccines are the most referred means of tackling the virus, but we think establishing these ideal management strategies is presently far-fetched. In-house isolation or quarantine of suspected cases to keep hospital admissions manageable and prevent in-hospital spread of the virus, and promoting general awareness about transmission routes are the practical strategies used to tackle the spread of COVID-19. Cases with weakened or compromised immune systems-for example, elderly individuals, young children, and those with pre-existing conditions such as diabetes, cancer, hypertension, and chronic respiratory diseases-are particularly more susceptible to COVID-19. Hopefully, cumulative data using whole-genome sequencing of the SARS-CoV-2 genome in parallel with mathematical modeling will help the molecular biologists to understand unknown features of the pathogenesis and epidemiology of COVID-19."],"journal":"Arch Med Res","authors":["Rahimi, Farid","Talebi Bezmin Abadi, Amin"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32229157","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.arcmed.2020.03.005","keywords":["covid-19","coronaviridae","pandemic","prevention","who","wuhan"],"locations":["Wuhan","China","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138492171714560,"score":59.348015}]}